KRAS and pancreatic adenocarcinoma: Thus, extensive evidence suggests that KRAS mutation may be an early and initiating event in human PAAD.[16] Studies have shown that genomic instability-associated lncRNAs are present in several types of tumors, such as gastric cancer,[17] but have rarely been reported in PAAD, a tumor with low mutation frequency.